- Home
- CLOV vs RXRX Comparison
CLOV vs RXRX Comparison
Compare CLOV & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLOV | RXRX |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLOV | RXRX |
|---|---|---|
| Price | $4.31 | $2.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $2.90 | ★ $7.50 |
| AVG Volume (30 Days) | 4.4M | ★ 14.8M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | 14.79 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $1,924,308,000.00 | $74,681,000.00 |
| Revenue This Year | $52.59 | $12.11 |
| Revenue Next Year | $15.37 | $82.52 |
| P/E Ratio | $42.70 | ★ N/A |
| Revenue Growth | ★ 40.34 | 26.92 |
| 52 Week Low | $1.58 | $2.77 |
| 52 Week High | $5.59 | $7.18 |
Technical Indicators
Market Signals| Indicator | CLOV | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.41 | 42.65 |
| Support Level | $4.12 | $2.87 |
| Resistance Level | $5.19 | $4.03 |
| Average True Range (ATR) | 0.24 | 0.13 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 12.15 | 18.09 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.